finanzen.net
15.03.2019 23:00
Bewerten
(0)

Global Antimicrobial Resistance Diagnostics Market Outlook to 2023 - Multiple Diagnostic Technologies Create New Global Race

DRUCKEN

DUBLIN, March 15, 2019 /PRNewswire/ -- The "Antimicrobial Resistance Diagnostics Market, Strategies & Trends By Pathogen and Technology with Executive Guides and Customization 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.

Diagnostics are leading the charge in reducing the threat posed by antimicrobial resistance.

New diagnostic technologies, beyond gene sequencing, are under development to capture this growing market. This report has looked at the technology picture, giving you plain language understanding of the different ways pathogens, and infections can be diagnosed.

The 6 Key Large Pathogen Opportunities in this space have been identified and market forecasts have been developed. The report includes profiles of 20 companies, large and small, working in this area.

Topics Covered

i. Antimicrobial Resistance - Strategic Situation Analysis
ii. Guide for Executives, Marketing, Sales and Business Development Staff
iii. Guide for Management Consultants and Investment Advisors

1. Introduction and Market Definition
1.1 The Growing Threat and Opportunity of Antimicrobial Resistance
1.2 Defining the Opportunity
1.2.1 Revenue Market Size
1.3 Methods and Sources
1.3.1 Authors
1.3.2 Sources
1.4 U.S. Antibiotic Markets - Perspective
1.4.1 U.S. Outpatient Use of Antibiotics
1.4.2 U.S. Pharmaceutical Spending

2. Overview of a Dynamic Market
2.1 Market Players - Roles & Impacts
2.1.1 Drug manufacturers - Larger/pharmaceutical
2.1.2 Drug manufacturers - Generic
2.1.3 Contract Research and Manufacturing
2.1.4 In Vitro Diagnostics Industry
2.1.5 Drug Marketing Companies
2.1.6 Biotechnology Companies
2.1.7 Regulatory Bodies
2.2 Understanding Antimicrobial Resistance
2.2.1 What is Antimicrobial Resistance (AMR)
2.2.2 Bacteria and Other Microbes
2.2.3 The History of Antibiotics
2.2.4 The Role of Animal Husbandry
2.2.5 The Implications of Horizontal Transfer
2.2.6 The Threat of AMR
2.3 The Changing Road to New Antibiotics & Technologies
2.4 The Key Role of Diagnostics in AMR

3. The Market Opportunity of AMR
3.1 The Key Large Market Opportunities in AMR
3.1.1 Streptococcus Pneumoniae (DRSP)
3.1.2 Campylobacter (DRC)
3.1.3 Clostridium Difficile (CD)
3.1.4 Staphylococcus aureus (MRSA)
3.1.5 Neisseria gonorrhoeae (DRNG)
3.1.6 Salmonella (DRNTS)
3.2 Diagnostic Technology Development Opportunities
3.2.1 What's Wrong with Microbiology
3.2.2 The Features Battleground of Infectious Disease Diagnostics
3.2.3 Multiplex vs. POC/Rapid
3.2.4 The Miracle of Genetics
3.2.5 From Multiple Pathogens to All Pathogens - The Next Next Generation
3.2.6 Gene Sequence Diagnostics WITHOUT the Sequencing
3.2.7 Markers of Resistance
3.2.8 What Happens to the Microbiology Lab?
3.4. Antibiotic Resistance Recent Developments
Importance of These Developments
How to Use This Section

  • Qiagen, Ares Genetics Ink Licensing Pact for AMR Bioinformatics
  • OpGen to File First 510(k) for AMR Gene Panel
  • Curetis' Subsidiary Ares Genetics Teams Up with Sandoz in Fight Against AMR
  • GeneCapture to determine antibiotic sensitivity in an automated rapid portable device
  • Quick identification of multidrug-resistant pathogens
  • OpGen to Offer Qiagen Nucleic Acid Purification Tech With Acuitas Pathogen Panel
  • Metagenomics Enables Researchers to Uncover Drug Resistance Genes
  • Rapid detection of multi-drug-resistant bacteria
  • Improved Diagnostics Fail to Halt the Rise of Tuberculosis
  • High Throughput Manufacturing Lines to Answer Growing Needs for Diagnosis Cartridges
  • New solution for diagnosing antibiotic-resistant bacteria
  • MALDI-TOF - Results in Minutes not Days
  • CRISPR Tool Used to Uncover Infections
  • Automated Blood Tests Startup MeMed Raises Funds, Wins Grant
  • BD, Check-Points Receive CE Mark for Resistant Organism Screening Test
  • LiDia BSI Detects Pathogens and Antimicrobial Resistance
  • New tool can Track Resistant Malaria
  • Rapid Test Developed to Measure Antibiotic Resistance in Patients with UTIs
  • Longitude Funds for POC Tests
  • New test can identify dangerous bacteria with resistance to last-resort antibiotic
  • bioMerieux receives FDA clearance for expanded pathogen identification capability
  • OpGen Inks Deal to Use Thermo Fisher PCR Tech in Acuitas Gene Panel Tests
  • Hospital Plumbing Harbors Antibiotic Resistant Bacteria
  • Acquisition Strategy Fills Out Roche's Diagnostic Pipeline
  • Curetis Gets Singapore Approval for Pneumonia Test
  • PlexBio, Denka to Codevelop Sepsis, Multidrug Resistance MDx
  • Curetis, MGI Collaborate to Combine Sample Prep, NGS Technologies

4. Key Biotechnology Companies and Their Technology
4.1 Diagnostics
4.1.1 1928 Diagnostics
4.1.2 Sense Biodetection
4.1.3 Fusion Genomics
4.1.4 Day Zero Diagnostics
4.1.5 Inflammatix
4.1.6 Hutman Diagnostics
4.1.8 bioMerieux Diagnostics
4.1.9 Curetis N.V. / Curetis GmbH
4.1.10 Great Basin Corporation
4.1.11 Becton, Dickinson and Company
4.1.12 Roche Diagnostics
4.1.13 Cepheid (now Danaher)
4.1.14 Atlas Genetics
4.1.14 Accelerate Diagnostics
4.1.15 Seimens
4.1.16 Abbott Diagnostics
4.1.17Thermo Fisher
4.1.18 Bio - Rad
4.1.19 GenePOC Diagnostics
4.1.20 Sysmex
4.1.21 Ortho Clinical

5. The Global Market
5.1 Global Market by Country

6. Global Market by Pathogens
6.1 Global Market by Pathogens
6.2 DRSP
6.3 DRC
6.4 CD
6.5 MRSA
6.5 DRNG
6.6 DRNTS

7. AMR Diagnostics by Technology
7.1 Global Market by Technology
7.2 Bacterial Culture
7.3 Immunoassay
7.4 Polymerase Chain Reaction
7.5 Genetic Sequencing
7.6 Mass Spectrometer
7.7 Rapid, POC and Other

8. Vision of the Future of AMR Diagnostics

For more information about this report visit https://www.researchandmarkets.com/research/km68mc/global?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Cision View original content:http://www.prnewswire.com/news-releases/global-antimicrobial-resistance-diagnostics-market-outlook-to-2023---multiple-diagnostic-technologies-create-new-global-race-300813262.html

SOURCE Research and Markets

Anzeige
Anzeige
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX schließt schwächer -- Dow beendet Handel zurückhaltend -- Deutsche Bank und Commerzbank loten offiziell Fusion aus -- Boeing, Daimler, Talanx, LEONI im Fokus

VW-Konzernchef Diess kauft in großem Stil Volkswagen-Aktien. Uber-Konkurrent Parlamentspräsident macht Regierung Strich durch die Rechnung. Lyft strebt Milliarden-Erlös bei Börsengang an. Italiens Aufseher verbieten ING Neukundengeschäft wegen Kontrollmängeln. Nordex-Aktien kratzen an 200-Wochen-Linie - Citi nicht mehr negativ.

Die 5 beliebtesten Top-Rankings

In diesen Ländern ist Netflix am teuersten
Hier müssen Abonnenten tief in die Tasche greifen
Die korruptesten Länder der Welt
In diesen Staaten ist die Korruption am höchsten
Abschlüsse der DAX-Chefs
Diese Studiengänge haben die DAX-Chefs absolviert
Erster Job
Wo Absolventen am meisten Geld verdienen
Das Schwarzbuch 2018/2019
Wo 2018 sinnlos Steuern verbrannt wurden
mehr Top Rankings

Umfrage

Nun ist es bestätigt: Deutsche Bank und Commerzbank loten offiziell eine Fusion aus. Glauben Sie, dass es tatsächlich dazu kommen wird?

finanzen.net Brokerage

Online Brokerage über finanzen.net

Das Beste aus zwei Welten: Handeln Sie für nur 5 Euro Orderprovision* pro Trade unmittelbar aus der Informationswelt von finanzen.net!
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Wirecard AG747206
CommerzbankCBK100
Deutsche Bank AG514000
Aurora Cannabis IncA12GS7
Daimler AG710000
Boeing Co.850471
Deutsche Telekom AG555750
LEONI AG540888
Amazon906866
SteinhoffA14XB9
Infineon AG623100
Apple Inc.865985
BASFBASF11
Allianz840400
TeslaA1CX3T